FOXP3 as a prognostic marker and therapeutic target in immunogenic cell death modulation for clear cell renal cell carcinoma
Jian Chen,
No information about this author
Cheng Zhu,
No information about this author
Yan He
No information about this author
et al.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 30, 2025
Abstract
Background
Clear
cell
renal
carcinoma
(ccRCC)
remains
a
challenging
cancer
type
due
to
its
resistance
standard
treatments.
Immunogenic
death
(ICD)
has
the
potential
activate
anti-tumor
immunity,
presenting
promising
avenue
for
ccRCC
therapies.
Methods
We
analyzed
data
from
GSE29609,
TCGA-KIRC,
and
GSE159115
identify
ICD-related
prognostic
genes
in
ccRCC.
By
applying
consensus
clustering,
patients
were
categorized
based
on
ICD
modification
patterns,
an
signature
(ICDS)
model
was
developed
using
PCA
approach.
Functional
studies
conducted
with
FOXP3
knockdown
lines
explore
impact
behavior.
Results
Eleven
identified
as
key
indicators
ccRCC,
high
ICDS
linked
worse
survival
outcomes.
High
also
correlated
increased
levels
of
immune-suppressive
cells
within
tumor
microenvironment.
highlighted
critical
gene
influencing
ICD,
where
significantly
reduced
proliferation
migration,
underscoring
role
progression.
Conclusions
This
study
establishes
pivotal
factor
regulation
Targeting
other
pathways
could
enhance
treatment
efficacy
providing
foundation
ICD-based
therapeutic
strategies.
Evaluating
patterns
may
guide
patient-specific
interventions,
paving
way
improved
management
this
aggressive
cancer.
Language: Английский
PROGNOSTIC SIGNIFICANCE OF FOXP3 IN RADICALLY TREATED NON-SMALL CELL LUNG CANCER PATIENTS
Art of Medicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 25 - 32
Published: April 2, 2025
Regulatory
T-cells
(Tregs),
which
are
characterized
by
the
expression
of
transcription
factor
Forkhead
box
P3
(Foxp3),
play
a
crucial
role
in
modulating
immune
response.
While
Tregs
primarily
recognized
for
their
immunosuppressive
functions,
influence
on
survival
and
prognosis
patients
with
non-small
cell
lung
cancer
(NSCLC)
presents
complex
often
variable
picture.
This
variability
can
manifest
range
outcomes,
influencing
patient
positive,
negative,
or
neutral
ways.
Our
study
aims
to
delve
into
prognostic
significance
Foxp3
undergoing
radical
treatment
NSCLC,
seeking
relationship
between
Treg
dynamics
outcomes.
involved
cohort
forty-two
diagnosed
at
stages
IA
IIIB,
all
whom
underwent
surgical
intervention
followed
an
adjuvant
regimen
platinum-based
chemotherapy.
The
inclusion
criteria
were:
who
had
previously
received
neoadjuvant
chemotherapy
radiation
therapy.
Those
experienced
postoperative
complications,
individuals
significant
concurrent
health
conditions
were
systematically
excluded
from
participation.
Comprehensive
clinicopathological
data
each
extracted
medical
records
ensure
accuracy
reliability.
To
evaluate
presence
FOXP3-positive
cells,
we
employed
immunohistochemistry
techniques
established
threshold
23
cells
per
1
mm².
Patients
subsequently
stratified
two
distinct
groups
based
FOXP3
levels:
low
group
(<23
cells/1
mm²)
high
(≥23
mm²).
We
compared
clinical
outcomes
these
ascertain
any
differences.
A
statistical
analysis
utilizing
Mann-Whitney
test,
Chi-squared
receiver
operating
characteristic
(ROC)
analysis,
Kaplan-Meier
method
Log-rank
test
comprehensively
data.
density
Foxp3-positive
lymphocytes
within
tumor
microenvironment
exhibited
notable
variability,
ranging
5
as
many
72
square
millimeter.
Interestingly,
revealed
no
associations
levels
selected
features
patients.
Moreover,
comparative
evaluation
showed
marked
differences
adenocarcinomas
squamous
carcinomas
respect
characteristics
examined.
Importantly,
versus
did
not
demonstrate
disparities
recurrence-free
overall
survival,
indicated
log-rank
p-values
0.1817
0.3944,
respectively.
However,
discernible
trend
emerged,
suggesting
that
exhibiting
lower
tended
experience
improved
RFS
OS
Research
indicates
both
survival.
Furthermore,
lack
correlation
associated
has
been
observed.
may
discrepancies
noted
Language: Английский
The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 9, 2024
The
ubiquitin-proteasome
system
(UPS)
plays
a
crucial
role
in
modulating
the
proliferation,
activation,
and
normal
functioning
of
immune
cells
through
regulation
protein
degradation
function.
By
influencing
expression
checkpoint-associated
proteins,
UPS
modulates
T
cell-mediated
anti-tumor
responses
can
potentially
facilitate
escape
tumor
cells.
Additionally,
contributes
to
remodeling
immunosuppressive
microenvironment
(TIME)
by
regulating
B
cells,
dendritic
(DCs),
macrophages,
Treg
Targeting
conjunction
with
combining
these
other
therapeutic
approaches,
may
significantly
enhance
efficacy
combination
therapies
pave
way
for
novel
cancer
treatment
strategies.
In
this
review,
we
first
summarize
composition
alterations
TIME,
particular
emphasis
on
TIME
its
interactions
various
cell
types.
Finally,
explore
potential
UPS-targeted
immunotherapy
substantially
improve
effectiveness
patient
survival
outcomes.
Language: Английский
Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma
Xiaoxia Zeng,
No information about this author
Dunhui Yang,
No information about this author
Jin Zhang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 10, 2024
Head
and
neck
squamous
carcinoma
(HNSC),
characterized
by
a
high
degree
of
malignancy,
develops
in
close
association
with
the
tumor
immune
microenvironment
(TIME).
Therefore,
identifying
effective
targets
related
to
HNSC
TIME
is
paramount
importance.
Here,
we
employed
ESTIMATE
algorithm
compute
stromal
cell
scores
for
samples
from
TCGA
database
identified
differentially
expressed
genes
(DEGs)
based
on
these
scores.
Subsequently,
utilized
four
machine
learning
algorithms
identify
key
genes:
ITM2A,
FOXP3,
WIPF1,
RSPO1
DEGs.
Through
comprehensive
pan-cancer
analysis,
our
study
aberrant
expression
ITM2A
across
various
types,
significant
TIME.
Specifically,
was
markedly
reduced
correlated
poor
prognosis
HNSC.
Functional
enrichment
analysis
revealed
that
implicated
multiple
immune-related
pathways,
including
immune-infiltrating
cells,
checkpoints,
immunotherapeutic
responses.
observed
populations
through
single-cell
analysis.
Furthermore,
showed
overexpression
inhibited
growth
cells.
Our
results
suggest
may
be
novel
prognostic
marker
associated
Language: Английский